According to the Skin Cancer Foundation, an estimated 196,060 cases of melanoma will be diagnosed in the U.S. in 2020. When detected and treated early, most types of skin cancer have extremely high survival rates. However, due to the COVID-19 pandemic and related restrictions, access to dermatological care is proving especially difficult this year for many Americans. The doctors at Moy Fincher Chipps Facial Plastics and Dermatology have faced this problem head-on, employing exclusive artificial intelligence called Triage Technology to provide high-quality telemedicine to its patients. When a patient submits a photograph, it examined by one of the clinic’s dermatologists as well as the artificial intelligence to detect and diagnose potential skin cancer before a biopsy. With this new device, patients can receive instant, accurate results without stepping a foot outside their home.
RELATED STORIES
First Derm Launches Skin Disease Search Engine
4 Out Of 5 People Won't Visit Med Spas Without Safety Standards
Alastin Skincare Announces Issuance of Fourth U.S. Patent Incorporating TriHex Technology